R10761 |
5-Chloro-2-[(3,4,4-trifluorobut-3-en-1-yl)sulfonyl]-1,3-thiazole |
CAS NO.:318290-98-1
Product Name:5-Chloro-; 5-chloro-; 5-Chloro-2-[(3,4,4-triflu
|
R10763 |
Kevetrin hydrochloride; NSC525990 |
Kevetrin hydrochloride is a small molecule and activator of the tumor suppressor
|
R10764 |
BMH-21 |
BMH-21 is a DNA intercalator, which binds ribosomal DNA and inhibits RNA polymer
|
R10766 |
SC-202671 |
JNK inhibitor IX is a selective and potent JNK inhibitor with pIC50 of 6.5 and 6
|
R10767 |
MPEP hydrochloride |
MPEP is a potent, highly selective non-competitive antagonist at the mGlu5a rece
|
R10768 |
KU-60019 |
KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cel
|
R10769 |
O4I2 |
O4I2 is a potent Oct3/4 inducer in various human cell lines including human fibr
|
R10770 |
1016535-83-3 |
|
R10771 |
O4I1 |
O4I1 is as a potent Oct3/4 inducer.Target: Oct3/4
|
R10773 |
220904-99-4 |
|
R10774 |
TG6-10-1 |
TG6-10-1 is an EP2 antagonist, shows low-nanomolar antagonist activity against o
|
R10775 |
B7/CD28 interaction inhibitor 1 |
B7/CD28 interaction inhibitor 1 (copmound 6b) is a potent B7.1-CD28 interaction
|
R10776 |
4-Keto13-cis-Retinoic Acid |
CAS NO.:71748-57-7Product Name:4-Keto 13-cis-Retinoic Acid Methyl EsterSynonyms:
|
R10777 |
bml-210 |
BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been ch
|
R10778 |
Pimelic diphenylamide 106; TC-H106 |
Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I HDAC (HD
|
R10779 |
UF010 |
UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 μ
|
R10780 |
KC7F2 |
KC7F2 is a potent HIF-1 pathway inhibitor and that its potential as a cancer the
|
R10781 |
WDR50103 |
WDR5-0103 is a potent and selective WD repeat-containing protein 5 (WDR5) antago
|
R10782 |
EXP-3174 |
Losartan Carboxylic Acid (E-3174), an active carboxylic acid metabolite of Losar
|
R10783 |
vorapaxar intermediate 1 |
|
R10784 |
vorapaxar intermediate 2 |
|
R10785 |
Savolitinib (Volitinib; HMPL-504; AZD-6094) |
Savolitinib(Volitinib; AZD-6094; Volitinib) is an orally bioavailable inhibitor
|
R10786 |
FMK |
FMK is a RSK2 kinase inhibitor.
|
R10789 |
CPI-203 |
CPI203 is a novel potent, selective and cell permeable inhibitor of the bromodom
|
R10790 |
2-(2,6-dimethylphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide |
|